FMP
PTC Therapeutics, Inc.
PTCT
NASDAQ
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.
54.5 USD
1.74 (3.19%)
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
38.23M
52.17M
32.41M
24.09M
41.27M
26.2M
22.32M
19.01M
16.2M
13.8M
1.38
2.97
2.06
1.73
2.99
2.23
2.23
2.23
2.23
445.9M
258.5M
193.03M
199.72M
147.77M
160.43M
136.68M
116.44M
99.2M
84.51M
16.14
14.7
12.29
14.38
10.71
13.64
13.64
13.64
13.64
534.51M
364.68M
421.48M
363.15M
276.42M
265.98M
226.6M
193.05M
164.47M
140.12M
19.35
20.74
26.84
26.15
20.03
22.62
22.62
22.62
22.62
400.98M
296.77M
251.07M
287.61M
249.88M
202.7M
172.69M
147.12M
125.34M
106.78M
14.52
16.87
15.99
20.71
18.1
17.24
17.24
17.24
17.24
-33.71M
-36.27M
-27.65M
-23.55M
-23.6M
-19.87M
-16.93M
-14.42M
-12.29M
-10.47M
-1.22
-2.06
-1.76
-1.7
-1.71
-1.69
-1.69
-1.69
-1.69